SelectQuote Target of Unusually Large Options Trading (NYSE:SLQT)

SelectQuote, Inc. (NYSE:SLQT) was the recipient of unusually large options trading activity on Friday. Stock traders purchased 4,430 call options on the stock. This represents an increase of 128% compared to the average daily volume of 1,943 call options.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on SLQT. Royal Bank of Canada reiterated a “sector perform” rating and set a $4.00 price target on shares of SelectQuote in a research report on Friday, November 22nd. Noble Financial upgraded shares of SelectQuote to a “strong-buy” rating in a research report on Wednesday, February 12th.

SelectQuote Trading Down 1.5 %

Shares of SLQT stock opened at $3.55 on Friday. The company has a debt-to-equity ratio of 2.10, a quick ratio of 6.36 and a current ratio of 6.36. The stock has a market capitalization of $610.25 million, a P/E ratio of -39.39 and a beta of 1.13. The company has a 50 day moving average price of $4.45 and a 200 day moving average price of $3.30. SelectQuote has a fifty-two week low of $1.48 and a fifty-two week high of $6.86.

SelectQuote (NYSE:SLQT) last announced its quarterly earnings data on Monday, February 10th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.21. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. Equities research analysts predict that SelectQuote will post -0.07 EPS for the current fiscal year.

Insider Buying and Selling

In other SelectQuote news, insider Sarah Taylor Anderson sold 50,000 shares of SelectQuote stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total transaction of $272,000.00. Following the completion of the sale, the insider now directly owns 1,166 shares in the company, valued at $6,343.04. This trade represents a 97.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 11.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its stake in SelectQuote by 1.7% in the fourth quarter. Vanguard Group Inc. now owns 7,363,421 shares of the company’s stock worth $27,392,000 after acquiring an additional 120,280 shares during the last quarter. Geode Capital Management LLC lifted its stake in SelectQuote by 1.4% in the third quarter. Geode Capital Management LLC now owns 3,081,391 shares of the company’s stock worth $6,688,000 after acquiring an additional 43,197 shares during the last quarter. State Street Corp lifted its stake in SelectQuote by 0.7% in the third quarter. State Street Corp now owns 2,894,067 shares of the company’s stock worth $6,280,000 after acquiring an additional 21,413 shares during the last quarter. Captrust Financial Advisors lifted its stake in SelectQuote by 5.0% in the fourth quarter. Captrust Financial Advisors now owns 1,542,010 shares of the company’s stock worth $5,736,000 after acquiring an additional 73,627 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in SelectQuote by 0.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,701 shares of the company’s stock worth $4,433,000 after acquiring an additional 10,038 shares during the last quarter. Institutional investors and hedge funds own 34.59% of the company’s stock.

SelectQuote Company Profile

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.